| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/07/06 | 05 : 07 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:XPAXU | XPAC Acquisition Corporation |
| 2024/07/06 | 05 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HYACU | Haymaker Acquisition Corp 4 |
| 2024/07/06 | 05 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SSNT | SilverSun Technologies Inc |
| 2024/07/06 | 05 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:XPAXU | XPAC Acquisition Corporation |
| 2024/07/06 | 05 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:FACT | Freedom Acquisition I Corp |
| 2024/07/06 | 05 : 05 | PR Newswire (US) | Dominion Energy Schedules Second-Quarter 2024 Earnings Call | NYSE:D | Dominion Energy Inc |
| 2024/07/06 | 05 : 05 | GlobeNewswire Inc. | Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | NASDAQ:FBIO | Fortress Biotech Inc |
| 2024/07/06 | 05 : 05 | GlobeNewswire Inc. | Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | NASDAQ:FBIOP | Fortress Biotech Inc |
| 2024/07/06 | 05 : 05 | PR Newswire (US) | Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | NASDAQ:SNDX | Syndax Pharmaceuticals Inc |
| 2024/07/06 | 05 : 05 | PR Newswire (US) | IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024 | NASDAQ:IDYA | IDEAYA Biosciences Inc |
| 2024/07/06 | 05 : 05 | GlobeNewswire Inc. | Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:CMRX | Chimerix Inc |
| 2024/07/06 | 05 : 05 | Business Wire | Enterprise Financial Services Corp Announces Second Quarter 2024 Earnings Release and Conference Call | NASDAQ:EFSC | Enterprise Financial Services Corporation |
| 2024/07/06 | 05 : 03 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:AMJ | JP Morgan Alerian MLP |
| 2024/07/06 | 05 : 02 | PR Newswire (US) | ProLux Announces Sponsorship of Rising Boxing Star Brady Ochoa | | |
| 2024/07/06 | 05 : 01 | Business Wire | Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:ATRA | Atara Biotherapeutics Inc |
| 2024/07/06 | 05 : 01 | Business Wire | SkyWest, Inc. Announces Second Quarter 2024 Results Call Date | NASDAQ:SKYW | SkyWest Inc |
| 2024/07/06 | 05 : 00 | The Daily Hodl | Total Crypto Market Cap Primed To Explode by Over 44x to $100,000,000,000,000, Says Raoul Pal – Here’s Why | COIN:SOLUSD | Solana |
| 2024/07/06 | 05 : 00 | The Daily Hodl | Total Crypto Market Cap Primed To Explode by Over 44x to $100,000,000,000,000, Says Raoul Pal – Here’s Why | COIN:FETUSD | Fetch |
| 2024/07/06 | 05 : 00 | The Daily Hodl | Total Crypto Market Cap Primed To Explode by Over 44x to $100,000,000,000,000, Says Raoul Pal – Here’s Why | COIN:BTCUSD | Bitcoin |
| 2024/07/06 | 05 : 00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:BSGM | BioSig Technologies Inc |
| 2024/07/06 | 05 : 00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:BSGM | BioSig Technologies Inc |
| 2024/07/06 | 05 : 00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:BSGM | BioSig Technologies Inc |
| 2024/07/06 | 05 : 00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:BSGM | BioSig Technologies Inc |
| 2024/07/06 | 05 : 00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:BSGM | BioSig Technologies Inc |
| 2024/07/06 | 05 : 00 | GlobeNewswire Inc. | Inventiva fait le point sur son programme clinique NATiV3 évaluant lanifibranor dans la MASH/NASH et sur sa situation financièr | EU:IVA | Inventiva |
| 2024/07/06 | 05 : 00 | GlobeNewswire Inc. | Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position | TG:6IV | Inventiva |
| 2024/07/06 | 05 : 00 | GlobeNewswire Inc. | Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position | EU:IVA | Inventiva |
| 2024/07/06 | 05 : 00 | GlobeNewswire Inc. | Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position | EU:IVA | Inventiva |
| 2024/07/06 | 05 : 00 | GlobeNewswire Inc. | Inventiva fait le point sur son programme clinique NATiV3 évaluant lanifibranor dans la MASH/NASH et sur sa situation financièr | TG:6IV | Inventiva |
| 2024/07/06 | 05 : 00 | Business Wire | Bank of Marin Bancorp to Webcast Q2 Earnings on Monday, July 29, 2024, at 8:30 a.m. PT | NASDAQ:BMRC | Bank of Marin Bancorp |